Abstract 1859P
Background
Cognitive impairment (CI) is a common late effect after cancer treatment, for which effective treatment is lacking. Goal Management Training (GMT) is a validated cognitive remediation protocol reported to improve cognition including perceived daily life executive functioning, in neurological conditions. However, GMT has never been examined in cancer survivors, nor been presented in a digital format. This study examined the feasibility and acceptability of digital GMT in cervical cancer survivors (CCS) with subjective and/or objective CI.
Methods
We invited 65 CCS with CI to participate. Participants were randomized in a 1:1 ratio between digital GMT and a computerized cognitive training (CCT) program (BrainHQ). GMT consists of six weekly group-based modules encompassing discussion of participants’ real-life cognitive deficits, practice on tasks of attention and self-monitoring, as well as homework assignments. BrainHQ is a web-based training platform with exercises targeting several cognitive domains. For six weeks, participants joined digital training sessions of one hour twice a week. The primary endpoint was attendance, and participants attending ≥80% of the sessions were categorized as completers. Acceptability was evaluated 1 week post-intervention using the Client Satisfaction Questionnaire-8 (CSQ-8). A total CSQ-8 score ≥ 26 was defined as “very satisfied”, scores 20-25 as “satisfied”, and scores <20 as “not satisfied”.
Results
33 CCS with a median age of 50.0 years (range 35-67) were randomized to either GMT (N = 16) or CCT (N = 17). In the GMT group, all participants completed the intervention (100%), compared to 15 (88%) in the CCT group. Median CSQ-8 in the GMT and CCT group was 25 (SD 3.7, range 18-31) and 24 (SD 3.1, range 19-30) respectively. Participants in both groups reported a high level of satisfaction as 40% reported being “very satisfied” and 53% “satisfied”.
Conclusions
A digital cognitive training program such as GMT is feasible with a high level of compliance and satisfaction in CCS and is suitable to be tested in a larger study. Exploratory analyses of neuropsychological assessments in our study will provide important preliminary data on the efficacy of improving cognitive function in CCS.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Jan Kåre Heiberg and Marthe Vildåsen.
Disclosure
K. lindemann: Financial Interests, Institutional, Research Grant, Grants or contracts, paid to institution: GSK; Financial Interests, Institutional, Advisory Board, Participation on Data Safety Monitoring/advisory board: Eisai, MSD, Nycode, AstraZeneca, GSK. All other authors have declared no conflicts of interest.
Resources from the same session
1614P - Integrated palliative care for patients referred for Chimeric Antigen Receptor T-cell (CAR-T) therapy: A service evaluation
Presenter: Rebekah Williams
Session: Poster session 05
1615P - Investigation of status of lung cancer palliative care management and concept and practice in Chinese medical providers
Presenter: Liling Ma
Session: Poster session 05
1845P - Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?
Presenter: Paul Matte
Session: Poster session 05
1846P - The impact of newly diagnosed early breast cancer on distress, perception of health and psychologic resilience
Presenter: Anuska Budisavljevic
Session: Poster session 05
1847P - Monitoring of psychological state and quality of life during Simonton-training for oncologic patients
Presenter: Petra Harasztosi
Session: Poster session 05
1849P - Use of antipsychotic drugs during radiotherapy in adult cancer patients in Korea: The nationwide retrospective cohort study based on the health insurance review and assessment service database
Presenter: JIN HWA CHOI
Session: Poster session 05
1851P - Psychological well-being of patients with colorectal cancer during the third wave of the COVID-19 pandemic: Results from cohort II of the PICO-SM study
Presenter: Konstantinos Kamposioras
Session: Poster session 05
1852P - Mental health among Tunisian oncologists
Presenter: nefzi issaad
Session: Poster session 05
1853P - Effect of logotherapy on anxiety in patients with cancer: A systematic review and meta-analysis
Presenter: Douglas Barroso
Session: Poster session 05
1854P - The role of “1 minute” time perception in evaluating depression and anxiety in cancer patients receiving chemotherapy
Presenter: Sait Kitaplı
Session: Poster session 05